Partner With Us NRI

Company details

6M Return 0.00%
1Y Return -5.44%
Mkt Cap.(Cr) 13.48
Volume 6,000
Div Yield 0.00%
OI Chg %
Volume 6,000

Open Free Demat Account Online with ICICIDIRECT


  • swot

  • technicals

  • deals

  • shareholding


Delivery and volume


  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio


Operating Profit(Cr.)

Profit after Tax(Cr.)


Reserves and Surplus



Operating Profit

Profit after tax





Equity Capital: 0.22 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 25,587.81 -37,752.78
LAST 3M 74,012.99 -52,283.98
LAST 6M 141,118.09 -186,787.74
LAST 12M 210,989.03 -181,030.70


  • About Company
  • Company Info
  • Listing Info
  • Achyut Healthcare Ltd is a private limited company incorporated on 11 January 1996 with Registrar of Companies, Gujarat, Dadra and Nagar Haveli. Pursuant to a special resolution of Shareholders passed in extra-ordinary general meeting held on 28 October 2002, the name of company was changed to `Achyut Healthcare Private Limited`, and a fresh certificate of incorporation dated 26 November 2002 was issued to Company by Registrar of Companies, Gujarat in Ahmedabad. Subsequently, pursuant to a special resolution of Shareholders passed in the extra-ordinary general meeting held on 8 November 2021, the Company was converted from a private limited company to public limited company and consequently, name of Company was changed to `Achyut Healthcare Limited`, and a fresh certificate of incorporation dated November 30, 2021 was issued to it by the Registrar of Companies, Gujarat at Ahmedabad. The Company is a pharmaceutical company dealing in API, trading pharmaceutical products and medical devices located in Ahmedabad, Gujarat. It is currently trading around 6 to 7 pharmaceutical products based on customers` requirements and customizations both to domestic and international borders with each product being traded having its own strengths and significant key areas. It involves in trading of Cenzure, Arpimune, Azathioprine IP, Everomimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium carbonate oyster, Cellulose acetate Phthalate, Chlorthalidone IP, Cross Carmalose Sod IP/USP, DI Basic Calcium Phosphate IP, DI Ethyl Phthlate, Diltiazem Hydrochloride IP, Easy Coat Fc Titanium Dioxide, Escitalopram IP, Escitalopram Oxalate, Favipiravir among many other products. In the year 2015, Company entered into business of trading in pharmaceutical products providing customized tailor made solutions to clients and customers. Presently, Company is into trading business in both domestic as well as International markets in countries namely UAE, Kenya and Nigeria.

Read More

Registered Address

610 Colonade B/H Iscon Temple, BRTS Bus Stand Iscon-Ambali Rd, Ahmedabad, Gujarat, 380058

Tel : 91-79-48982691
Email : compliance:achyuthealthcare.com
Website : http://www.achyuthealthcare.com


KFin Techologies Ltd

AGM Date (Month) :
Face Value Equity Shares : 10
Market Lot Equity Shares : 6000
BSE Code : 543499
NSE Code :
Book Closure Date (Month) :
BSE Group : MT
ISIN : INE0K1401012

ICICIdirect Achyut Healthcare Ltd FAQ

You can buy Achyut Healthcare Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Achyut Healthcare Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 13, 2022 04:00 PM the closing price of Achyut Healthcare Ltd was ₹ 20.00.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 13, 2022 04:00 PM, the market cap of Achyut Healthcare Ltd stood at ₹ 13.48.
The latest PE ratio of Achyut Healthcare Ltd as of May 13, 2022 04:00 PM is 0
The latest PB ratio of Achyut Healthcare Ltd as of May 13, 2022 04:00 PM is 0.67
The 52-week high of Achyut Healthcare Ltd is ₹ 21.50 while the 52-week low is ₹ 19.90 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote